BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22984562)

  • 1. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
    PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
    Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
    Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
    Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
    Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
    Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
    Heimerl S; Bosserhoff AK; Langmann T; Ecker J; Schmitz G
    Melanoma Res; 2007 Oct; 17(5):265-73. PubMed ID: 17885581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.
    Marie KL; Sassano A; Yang HH; Michalowski AM; Michael HT; Guo T; Tsai YC; Weissman AM; Lee MP; Jenkins LM; Zaidi MR; Pérez-Guijarro E; Day CP; Ylaya K; Hewitt SM; Patel NL; Arnheiter H; Davis S; Meltzer PS; Merlino G; Mishra PJ
    Nat Commun; 2020 Jan; 11(1):333. PubMed ID: 31949145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells.
    Liu S; Howell PM; Riker AI
    Ann Surg Oncol; 2013 May; 20(5):1745-52. PubMed ID: 22752337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
    Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
    Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA-array profiling of melanomas and paired melanocyte cultures.
    Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
    J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma.
    Estler M; Boskovic G; Denvir J; Miles S; Primerano DA; Niles RM
    BMC Genomics; 2008 Oct; 9():478. PubMed ID: 18847503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
    Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
    Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
    Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.